Mycophenolate mofetil and Hyperthyroidism aggravated - a phase IV clinical study of FDA data

Summary:

Hyperthyroidism aggravated is reported as a side effect among people who take Mycophenolate mofetil (mycophenolate mofetil), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Prograf, and have Hypothyroidism.

The phase IV clinical study analyzes which people have Hyperthyroidism aggravated when taking Mycophenolate mofetil. It is created by eHealthMe based on reports of 93,176 people who have side effects when taking Mycophenolate mofetil from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Hyperthyroidism aggravated?

Hyperthyroidism aggravated (over activity of the thyroid gland) is found to be associated with 882 drugs and 362 conditions by eHealthMe. Check the latest studies of Hyperthyroidism aggravated.

On Jul, 23, 2026

93,176 people reported to have side effects when taking Mycophenolate mofetil.
Among them, 51 people (0.05%) have Hyperthyroidism aggravated.

Could Mycophenolate mofetil cause Hyperthyroidism aggravated?

Among these 51 people:

How long have people been on Mycophenolate mofetil when they have Hyperthyroidism aggravated? *

What is the gender of people who have Hyperthyroidism aggravated when taking Mycophenolate mofetil? *

female: 31.82 %
male: 68.18 %

What is the age of people who have Hyperthyroidism aggravated when taking Mycophenolate mofetil? *

What are other drugs people take besides Mycophenolate mofetil? *

What are other side effects people have besides Hyperthyroidism aggravated? *

Anaemia (lack of blood): 21 people, 41.18%
Toxic Neuropathy (nerve damage caused by toxic (harmful) substances): 20 people, 39.22%
High Blood Cholesterol: 20 people, 39.22%
Optic Atrophy (the loss of a proportion of optic disc nerve fibres): 20 people, 39.22%
Hypertriglyceridaemia (excess of triglycerides in the blood): 20 people, 39.22%
Optic Nerve Disorder (disease of optic nerve): 20 people, 39.22%
Visual Field Defect: 20 people, 39.22%
Toxic Optic Neuropathy (optic nerve damage caused by toxic (harmful) substances): 19 people, 37.25%
Complications Of Transplanted Kidney: 18 people, 35.29%
Drug Intolerance (drug sensitivity): 5 people, 9.80%

What are the existing conditions these people have? *

Hyperlipidaemia (presence of excess lipids in the blood): 20 people, 39.22%
Hepatitis B: 20 people, 39.22%
High Blood Pressure: 20 people, 39.22%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 20 people, 39.22%
Immunodeficiency Disorders: 5 people, 9.80%
High Blood Cholesterol: 4 people, 7.84%
Vasculitis (inflammation of a blood vessel or blood vessels): 4 people, 7.84%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 5.88%
Haematopoietic Stem Cell Mobilisation: 2 people, 3.92%
Interstitial Lung Disease: 1 person, 1.96%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and have Hyperthyroidism aggravated?

- Check whether Hyperthyroidism aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mycophenolate mofetil:

Mycophenolate mofetil (93,460 reports)

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperthyroidism aggravated:

Hyperthyroidism aggravated (882 drugs)

Browse all the conditions that are associated with Hyperthyroidism aggravated:

Hyperthyroidism aggravated (362 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.